26th Sep 2013 08:52
LONDON (Alliance News) - Avacta Group PLC Thursday said that it had launched Sensipod, an in-clinic blood analysis system to veterinary practices in the UK.
Sensipod is a diagnostic system designed to detect markers of disease in blood samples. It is being launched in the UK with its first test, an allergy pre-screen, to identify allergies in dogs.
Shares in the biotechnology company were trading up 6% at 0.914 pence Thursday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Avacta Group